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We have examined the pre-steady-state kinetics and thermodynamic properties of the b hemes in variants of the yeast cytochrome bc1 complex
that have mutations in the quinone reductase site (center N). Trp-30 is a highly conserved residue, forming a hydrogen bond with the propionate on
the high potential b heme (bH heme). The substitution by a cysteine (W30C) lowers the redox potential of the heme and an apparent consequence
is a lower rate of electron transfer between quinol and heme at center N. Leu-198 is also in close proximity to the bH heme and a L198F mutation
alters the spectral properties of the heme but has only minor effects on its redox properties or the electron transfer kinetics at center N. Substitution
of Met-221 by glutamine or glutamate results in the loss of a hydrophobic interaction that stabilizes the quinone ligands. Ser-20 and Gln-22 form a
hydrogen-bonding network that includes His-202, one of the carbonyl groups of the ubiquinone ring, and an active-site water. A S20T mutation
has long-range structural effects on center P and thermodynamic effects on both b hemes. The other mutations (M221E, M221Q, Q22E and Q22T)
do not affect the ubiquinol oxidation kinetics at center P, but do modify the electron transfer reactions at center N to various extents. The pre-
steady reduction kinetics suggest that these mutations alter the binding of quinone ligands at center N, possibly by widening the binding pocket
and thus increasing the distance between the substrate and the bH heme. These results show that one can distinguish between the contribution of
structural and thermodynamic factors to center N function.
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The cytochrome bc1 complex is an energy transducing
integral membrane enzyme that links the transfer of electrons
from ubiquinol to cytochrome c to proton translocation across
the membrane via the protonmotive Q cycle [1,2]. In the absence
of a protonmotive force to provide energy, the quinol oxidation
reaction at center P is essentially irreversible, and the two
electrons from quinol follow divergent pathways through the
bc1 complex. One electron is transferred to the high potential
acceptors, the Rieske iron–sulfur protein and cytochrome c1.
The second electron from quinol oxidation enters the low
potential chain in cytochrome b through the low potential bAbbreviations: bL heme, Low potential b heme; bH heme, High potential b heme
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doi:10.1016/j.bbabio.2007.08.005heme (bL heme) and than transfers to the high potential heme (bH
heme) at center N, where it reduces quinone to form a stable
semiquinone. A second quinol oxidation reaction at center P
completes the cycle with the reduction of semiquinone to quinol
at center N.
In order for the bH heme to reduce both quinone and
semiquinone the semiquinone must be stabilized so that the
reduction potentials required for the two electron transfer
reactions are not significantly different. However, the structural
basis of semiquinone stabilization at center N is not presently
clear. We previously proposed that inter-monomer communica-
tion through the bL heme might be important [3,4]. In addition,
thermodynamic factors such as the redox potential of the bH
heme together with different binding affinities for the quinone
ligands may also contribute to the presence of semiquinone as a
long-lived intermediate at center N [5]. The availability of a
high-resolution structure of the yeast bc1 complex [6] allows the
opportunity to revisit some previously reported center Nmutants
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dynamic and structural parameters to center N function.
In the present study we have examined the bc1 complexes
from seven center N yeast mutants. These were obtained as
revertants of respiratory-deficient yeast strains [9,10] or as
mutations that conferred resistance towards ilicicolin H, a novel
center N inhibitor [7]. All of the mutants exhibited normal
growth on non-fermentable carbon sources and normal cyto-
chrome c reductase activities of the mitochondrial membranes.
The pre-steady-state reduction kinetics of the bc1 complexes
isolated from these mutants were examined in the presence of
inhibitors that differentiate reduction of cytochrome b through
center P and center N. The results are discussed with respect to
the thermodynamic properties of the bH heme and binding
affinity of center N for quinone ligands.
2. Materials and methods
2.1. Materials
Dodecyl maltoside was obtained from Anatrace. DEAE-Biogel and Tween-
20 were obtained from Bio-Rad Laboratories. Antimycin, diisopropylfluoropho-
sphate, decyl-ubiquinone and myxothiazol were purchased from Sigma
Chemical Co. Dithionite was purchased from Fluka Biochemica. Decyl-
ubiquinol was prepared as described before and quantified spectrophotometri-
cally using the reported extinction coefficient [11].
2.2. Purification of cytochrome bc1 complexes
The yeast strains with the KM91 background and the cytochrome b
mutants M221Q, M221E and W30C [10,12] were obtained from Dr. Anne-
Marie Colson (Universite Catholique de Louvain-La-Neuve, Belgium) and Dr.
Gael Brasseur (CNRS Marseille, France). The yeast strains with the W303
background and cytochrome b mutants S20T, Q22E, Q22T and L198F were
described in Ref. [7]. Cytochrome bc1 complexes from wild-type yeast and
mutant strains were purified as described previously [13]. Cytochrome bc1
activity was determined in assay buffer containing 50 mM potassium
phosphate, pH 7.0, 1 mM sodium azide, 1 mM EDTA and 0.01% Tween-
20, using 50 μM decyl-ubiquinol and 50 μM cytochrome c. The
quantifications of purified enzymes were performed spectrophotometrically
as described previously [14], using extinction coefficients of 17.5 mM−1 cm−1
at 554−539 nm for cytochrome c1 [15] and 50 mM−1 cm−1 at 562−578 nm
for the combined bH and bL hemes in cytochrome b [16].
2.3. Pre-steady-state reduction of bc1 complexes
The reduction of cytochrome b and cytochrome c1 was followed at 24 °C by
stopped flow rapid scanning spectroscopy using the OLIS rapid scanning
monochromator [14]. Reactions were started by rapid mixing of 2 μM enzyme in
assay buffer, containing 0.05% Tween-20, with an equal volume of assay buffer,
containing 0.05% Tween-20 and different concentrations of decyl-ubiquinol.
Two equivalents of antimycin or myxothiazol were added to the enzyme syringe,
if noted. For each experiment, 4–8 data sets were averaged and the oxidized
spectrum was subtracted. The kinetic traces were further processed using OLIS
software, exported to Origin and manipulated as described previously [4] to
obtain the absorbance changes attributable to cytochrome c1 and cytochrome b.
The absorbance changes were fitted to either a monophasic or a biphasic ex-
ponential function.
2.4. Redox titrations
Potentiometric titrations were performed at 24 °C in a 3.5-ml quartz cuvette,
as described previously [17], and the redox status of the b hemes was monitored
spectrophotometrically. The potential was measured with a platinum–Ag/AgCl(3 M) micro-electrode (MI-80414-6, Microelectrodes, Inc.). All values were
expressed with respect to the normal hydrogen electrode (NHE). The electrode
was calibrated against a pH 7 standard solution of quinhydrone (Em=+296 mV
versus NHE). The purified cytochrome bc1 complexes were diluted to 2 μM in
50 mM potassium phosphate pH 7 with 0.05% Tween-20. Redox equilibration
between the protein and the electrode was achieved by a mixture of the
following dyes (with their respective midpoint potential versus NHE at pH 7):
70 μM 2,3,5,6-tetramethyl-p-phenylenediamine (+240 mV), 25 μM 1,2-
naphtoquinone (+144 mV), 25 μM phenazine methosulfate (+80 mV), 25 μM
phenazine ethosulfate (+55 mV), 50 μM duroquinone (+5 mV), 30 μM
menaquinone (−76 mV), 50 μM 2-hydroxy-1,4-naphtoquinone (−145 mV),
30 μM anthraquinone-2,6-disulfonate (−184 mV) and 30 μM anthraquinone-2-
sulfonate (−225 mV). A 10 or 100 mM solution of dithionite or ferricyanide was
used for the reductive and oxidative titrations, respectively. The visible spectra
were recorded between 500 and 600 nm. The absorbances at 562−578 nm, after
subtracting the oxidized spectrum, were plotted against the potential of the
system. The graphed data were fitted to a double n=1 Nernst equation, using the
Origin program, to obtain the redox potentials for the bH and bL hemes [5]. The
Nernst plots for the oxidative and reductive titration exhibited no hysteresis,
confirming that the system was at equilibrium.
2.5. Molecular modeling
Structural changes associated with the mutations in cytochrome b were
modeled into the yeast cytochrome bc1 complex, using the coordinates of the
stigmatellin-liganded enzyme (PDB 1EZV, Ref. [6]). Computations were
performed on a Silicon Graphics O2™ work-station using programs included
in Insight II® (Accelrys, Inc. San Diego). The molecular dynamics and energy
minimization calculations were done with the Discover® program, using the
CVFF and CFF91 force fields. The modeling focused on the cytochrome b
subunit of the bc1 complex, along with associated heme groups and buried
water molecules. The heme iron atoms were removed temporarily from the
model in order to make the structure compatible with the force fields. The
effect of this removal was negligible, as the heavy atoms were located in
regions of the molecule that were fixed during simulation. The atomic
potentials were then assigned using the automatic function within the Insight
II® software.
Mutations were introduced into the cytochrome b structure using the
Biopolymer® module. Three subsets were created within each structure in order
to facilitate modeling. The central subset was left flexible in the key regions
near the mutations. Surrounding the flexible subset was a 5-Å radius shell of
fixed residues designed to anchor the flexible subset within the larger complex.
Finally, the most distant residues were placed in a subset excluded from
modeling in order to speed simulation. The flexible subset for the W30C mutant
structure consisted of cytochrome b residues 17–38 that are part of helix A and
the preceding loop region, in addition to a 6-Å radius around Trp-30. This
subset was designed to allow the mutated residue a fair amount of freedom in
sampling conformational space. Both of the hemes were included in the
calculations with their positions fixed. This technique was used in order to
accent the structural effects of mutation-induced conformational changes
relative to the heme groups.
Following a brief steepest descent minimization, the structure was subjected
to a full molecular dynamics simulation. Non-bonding interaction calculations
were limited to 9.5 Å, the dielectric constant was set to 2.0, and the temperature
held constant at 298 K. Each simulation began with 5000 fs of equilibration
using a 1.0 fs per iteration time step and the velocity scaling temperature control
method. Molecular dynamics simulation was continued for an additional 50 ps
using a 0.5 fs per iteration time step and the more accurate Nosé temperature
control method. Successful equilibration was judged by plotting both the
running and batch averages for the total energy versus time. Equilibrium was
reached when the batch-average energies oscillated smoothly around the
constant running-average energy. During molecular dynamics, the structures
were saved every 50 fs. Upon reaching equilibrium, the lowest energy structure
from each run was selected for a full minimization. Minimization was carried out
to a final convergence of 0.001, using the steepest descent, conjugate gradient,
and Newton (BFGS) methods in succession. Two runs were performed for the
structure of the mutated protein and then compared to the wild-type structure by
superposition.
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3.1. Location of mutations in cytochrome b
The Met-221 and Trp-30 mutations were originally isolated
as non-native, intragenic revertants of cytochrome b mutations
in a KM91 yeast strain. The original M221K mutation [18]
resulted in a respiratory deficient phenotype that was corrected
by substitution of lysine with glutamate (M221E) or glutamine
(M221Q) [9]. The third strain, containing the W30C mutation,
was obtained after segregating this mutation from the respiratory
competent, but thermo-labile W30C/S206L parent strain [10].
This strain was obtained as a revertant of the S206L strain that
had a respiratory-deficient phenotype [18]. The W30C strain
grew normally on non-fermentable carbon sources and did not
have the thermo-sensitive phenotype of theW30C/S206L parent
strain.
The yeast strains containing the cytochrome b mutations of
Ser-20 (S20T), Gln-22 (Q22T and Q22E) and Leu-198 (L198F)
were previously selected for resistance of the W303 parental
strain towards the novel center N inhibitor, ilicicolin H [7]. The
growth phenotype of the yeast on non-fermentable carbon
sources and preliminary biochemical analyses of cytochrome
bc1 complexes in the mitochondrial membranes isolated from
these mutants indicated that these mutations had no significant
effect on the steady-state activity or stability of the bc1 complex
in the membranes.
The locations of the mutations in center N of cytochrome b
are shown in Fig. 1. Trp-30 and Leu-198 are in close proximity
of both the quinone and the porphyrin rings (Fig. 1A). The
tryptophan forms a hydrogen bond with one of the propionate
groups of the heme bH and is highly conserved, as can be seenFig. 1. Views of center N and the location of the center N mutations in relation to th
which have been mutated in the current study, in relation to the bH heme ring and ubiq
also shown. Panel B shows the location of Ser-20, Gln-22 and Met-221, which are als
is the hydrogen bonded water molecule between Ser-20, His-202 and a carbonyl oxyg
are red, nitrogen atoms are blue and the heme iron is pink. The ribbon diagrams show
194–231. Coordinates are from the yeast structure [6] (Protein Data Bank code 1EZfrom the sequence alignments in Fig. 2. Leu-198 is located on
the other side of the porphyrin ring, forming a hydrophobic
interaction with ubiquinone and the bH heme. It is also located
next to one of the axial ligands to the heme bH iron, His-197.
Leu-198 is only weakly conserved and is replaced by other
hydrophobic residues, including isoleucine, phenylalanine and
methionine in the cytochrome bs from other species (Fig. 2 and
Ref. [19]).
The other three residues are located within 5 Å of each
other, on the other side of the quinone ring with respect to the
bH heme (Fig. 1B). Met-221 forms a hydrophobic interaction
with the ubiquinone. This interaction appears to be highly
conserved based on the structures from bovine [20], chicken
[21] and Rhodobacter capsulatus [22], but the counterpart
residue in these and most cytochrome bs is a phenylalanine
(Fig. 2, Ref. [19]). Ser-20 and Gln-22 appear to be part of a
hydrogen bonding network that also includes the active site
water, His-202, and one carbonyl groups of the ubiquinone
(Fig. 1B). Although these residues are not conserved and are
substituted by hydrophobic and aliphatic residues in cyto-
chrome bs of other species (Fig. 2, Ref. [19]), their
involvement in hydrogen bonding to the active site water
may make them of unique importance to quinone binding at
center N in the yeast enzyme.
3.2. Effect of cytochrome b mutations on properties of the
b hemes
Optical spectra of the cytochrome bc1 complexes purified
from the center N mutants and the wild-type parental strains
showed that, with the exception of the L198F mutant, there is no
obvious changes in the cytochrome b spectral properties as ae bH heme and ubiquinone. Panel A shows the location of Trp-30 and Leu-198,
uinone (Q) bound at center N. His-197, which is one of the axial heme ligands, is
o sites of mutations, in relation to the bH heme ring and ubiquinone. Also shown
en on ubiquinone. In both panels carbon atoms are colored green, oxygen atoms
the backbone structure of cytochrome b from residues 15-40 and from residues
V).
Fig. 2. Sequence alignment of the cytochrome b proteins from several species in the regions including residues 15–40 and 194–231 forming the ubiquinone reduction
pocket at the center N site. The alignment was constructed using ClustalWand yeast numbering. The numbered lines show the positions of the center N mutations that
were analyzed, plus His-202 and Ser-206. The species are Saccharomyces cerevisiae, Candida glabrata, Bos taurus, Gallus gallus, Rhodobacter capsulatus, and
Paracoccus denitrificans.
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type parental strain. The α-band of the reduced cytochrome b is
at 562 nm and there is no change in the b:c1 ratio of 2 to 1 (results
not shown). The L198F mutation has a hypsochromic effect on
the α-band, shifting it by ∼0.5 nm (Fig. 3). The resulting
difference spectrum of the L198F and wild-type enzymes has a
peak at 559 and a trough at 564 nm (Fig. 3). Assuming the same
ratio of b hemes to cytochrome c1, the extinction coefficient for
the b hemes appears not to be changed.
The redox midpoint potentials of the two b hemes that were
determined by potentiometric titration at pH 7 and monitored
spectrophotometrically are presented in Table 1. With the bc1
complex from the two wild-type parental strains we obtained
midpoint potentials of∼80 mVand∼−56 mV for the bH and bLFig. 3. Absorption spectra of reduced minus oxidized cytochrome bc1
complexes from wild-type yeast and the L198F mutant. Spectra were recorded
before and after reduction of 1 μM enzyme with dithionite. The solid line is the
spectrum of the enzyme from wild-type yeast (W303 strain) and the dotted line
is of the L198F mutant enzyme. The dashed line shows the difference spectrum
of the L198F mutant enzyme minus the spectrum of the bc1 complex from wild-
type yeast, expanded by a factor of five.heme, respectively (Fig. 4). Within the experimental error of the
methodology, the midpoint potentials of the bH and bL hemes in
five of the seven mutants, M221E, M221Q, Q22E, Q22T and
L198F, are very similar or changed only a small amount com-
pared to those of the b hemes in the wild-type enzymes (Fig. 4,
Table 1). Surprisingly the S20T mutation also induces a small
shift in the redox potential of both b hemes, although this residue
is not in close contact with either heme. Apparently this mutation
has some long-range structural effects that impact the thermo-
dynamic properties of the bH and bL hemes.
The bc1 complex from the W30C mutant also shows a clear
shift in its potentiometric titration curve (Fig. 4B), decreasing theTable 1
Ubiquinol–cytochrome c reductase activities and redox midpoint potentials for
the b hemes of the bc1 complexes from wild-type yeast strains and center N
mutants
Strain TN (s−1) b Em7 (mV)
a
bL bH
KM91 background
KM91(wild type) 150–180 −53 +79
M221Q 90–150 −47 +76
M221E 120–180 −63 +63
W30C 140–170 −58 +32
−34 c +53 c
W303 background
W303 (wild type) 200–290 −60 +82
S20T 140 −70 +59
Q22T 230–250 −56 +70
Q22E 260 −60 +77
L198F 260 −60 +80
Experimental conditions are described in Materials and methods.
a Values are for the reductive titration with the trace for the oxidative titration
very similar to the reductive titration. Data were fitted to a double Nernst
function with the bH heme contributing ∼70% and the bL heme ∼30% to the
total absorbance of the b heme at 562 nm, as described in Materials and
methods.
b TN=turn-over number.
c Data were fitted to a double Nernst function with bH and bL heme
contributing equally to the total absorbance of the b heme at 562 nm.
Fig. 4. Potentiometric titrations of the b hemes in wild-type cytochrome bc1 complex and bc1 complexes from the center N mutants. Potentiometric titrations were
performed at pH 7 and the redox status of the b hemes was monitored spectrophotometrically, as described under Materials and methods. Panel A shows the curves for
reductive redox titrations of the b hemes in bc1 complexes from the KM91 wild-type strain (closed circle), and the M221Q (open square) and W30C (closed triangle)
mutants. Panel B shows the heme b titrations curves of the bc1 complexes from the W303 wild-type strain (closed circle), and the L198F (closed triangle) and S20T
(open diamond) mutants. The solid lines in panels A and B are the fits to a double Nernst function with the bL and bH heme contributing∼30 and∼70%, respectively,
to the total heme b absorbance. The complete data set of absorbance versus wavelength at different redox potentials for the KM91 wild-type and W30C enzymes are
available as Supplemental data, Tables 1 and 2, respectively.
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∼40 mV. The best fit to a double Nernst function was obtained
when it was assumed that the bH and bL hemes contribute
equally to the total absorbance at 562−578 nm, which is
different from the 70:30 ratio in the other bc1 complexes. This fitFig. 5. Dependence of pre-steady-state cytochrome b reduction rates on decyl-ubiqui
of the first (fast) phase of cytochrome b reduction in the cytochrome bc1 compl
backgrounds, respectively. In panel A, rates for the KM91 wild-type enzyme are repr
W30C by solid triangles. In panel B, rates for the W303 wild-type enzyme are represe
closed squares, and L198F by closed triangles.calculates a decrease in the midpoint potential of the bH heme by
∼20 mV and an increase of the bL heme by ∼20 mV. On the
other hand, fixing the contribution of bH heme at 70% also gives
a satisfying fit. In this case the redox midpoint potential of the bL
heme is similar to the other bc1 complexes and the bH heme isnol concentration in the presence of myxothiazol. Panels A and B show the rates
exes from wild-type yeast and center N mutants with the KM91 and W303
esented by solid circles, M221E by open squares, M221Q by solid squares, and
nted by solid circles, S20T by open diamonds, Q22T by open squares, Q22E by
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calculated fittings is discussed further below.
3.3. Effect of cytochrome b mutations on steady-state kinetic
properties of the bc1 complex
Cytochrome c reductase activities of the purified cyto-
chrome bc1 complexes from the two wild-type strains and the
center N mutant strains are shown in Table 1. Variable
delipidation during purification is probably responsible for the
variability in steady-state activities from different batches, but
in each genetic background, most of the mutants exhibit close
to wild-type activity. The one exception is the bc1 complex
with the S20T mutation, which decreases the turnover number
by ∼50%. None of the mutations affected the dependence of
the activity on decyl-ubiquinol concentration, with an apparentFig. 6. Pre-state reduction of cytochrome b by decyl-ubiquinol in the presence of myx
cytochrome bc1 complex from the KM91 wild-type yeast strain (black), and the bc1
strains upon mixing with 24 μM decyl-ubiquinol. Panels C and D show the reduction
(black), and S20T (grey, panel C) and Q22E (grey, panel D) mutant strains reduced w
function. Rates and extent of reduction of the bH heme (%) are indicated for each trac
and values for the enzymes from the mutants shown below the traces.Km of ∼10 μM for all of the isolated enzymes (results not
shown).
3.4. Effect of cytochrome b mutations on the pre-steady-state
reduction of the b hemes through center N
Myxothiazol blocks quinol oxidation at center P, preventing
reduction of the high potential chain, the Rieske iron–sulfur
cluster and cytochrome c1, but the low potential chain, cyto-
chrome b, can still be reduced by decyl-ubiquinol through
center N. This makes it possible to study specifically the effects
of the center N mutations on the electron transfer reaction
through the quinone reduction site. Fig. 5 shows the rates of the
first (fast) reduction phase of the b hemes as a function of decyl-
ubiquinol concentration. The results in panel A show that the
mutations of Met-221 and Trp-30 decrease the rate of heme bothiazol. The traces in panels A and B show the reduction of cytochrome b in the
complexes from the M221E (grey, panel A) and W30C (grey, panel B) mutant
of cytochrome b in the cytochrome bc1 complex from the W303 wild-type strain
ith 20 μM decyl-ubiquinol. The traces were fitted to a monophasic or biphasic
e, with values for the enzymes from the wild-type strains shown above the traces
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from the KM91 wild-type strain. While the rates for the enzyme
from the wild-type strain are non-saturating over the range of
decyl-ubiquinol concentration measured, the rates for the en-
zymes from the Met-221 and Trp-30 mutants deviate from a
linear relationship as the concentration increases. All of the
mutations to Ser-20, Gln-22, and Leu-198 also affect the rate of
b heme reduction compared to the rate with the enzyme from the
W303 wild-type strain (Fig. 5B), with the most pronounced
decrease caused by the S20T mutation. The rates are non-
saturating for the W303 wild-type enzyme as the concentration
of decyl-ubiquinol increases, as well as for the enzyme from the
Q22Tand L198F mutants, while the rates of the Q22E and S20T
enzymes saturate at the higher concentrations.
Fig. 6 shows representative kinetic traces for reduction of
cytochrome b through center N in the bc1 complexes from the
M221E and W30C mutants compared to the KM91 wild-type
enzyme, and from the S20T and Q22E mutants compared to the
W303 wild-type enzyme. With the exception of the enzyme
with the W30C mutation in cytochrome b, all of the curves
could only be fitted to two phases. Most of the center N muta-
tions, with the exception of S20T, appear to have no significant
effect on the total extent of reduction, including the M221Q,
Q22T and L198F mutations (data not shown), while all of the
mutations affect the rate of b reduction to differing extents. The
S20T cytochrome b mutation has the most profound effects,
causing an∼40% decrease in extent and ∼90% decrease in rate
of cytochrome b reduction compared to the enzyme from the
W303 wild-type yeast (Fig. 6C). These changes, combined with
the effects on the midpoint potentials of both b hemes noted
above suggest that this mutation extensively damages the bc1
complex. Whereas the ∼50% decrease in rate of cytochrome b
reduction resulting from the W30C mutation (Fig. 6B) is con-
sistent with the change in midpoint potential of the bH heme in
this enzyme, the decreased rates resulting from the M221E
(Fig. 6A) and Q22E (Fig. 6D) mutations cannot be explained on
thermodynamic grounds. These are discussed in more details
below.
3.5. Effect of cytochrome b mutations on the pre-steady-state
reduction of b and c1 hemes through center P
To probe the influence of the center N mutations on the
quinol oxidation reaction at center P, pre-steady-state reduction
studies were performed in the presence of antimycin to block
reduction of the b hemes through center N. Kinetic traces for
reduction of the cytochrome bc1 complexes from the wild-type
strains and six selected mutants are shown in Fig. 7. The rates of
reduction of the b and c1 hemes in most of the mutant enzymes
are similar to those in the bc1 complexes from the wild-type
strains. Subtle changes are observed for the W30C mutant, with
a 50% increase in the rate of heme c1 reduction. There was also
a ∼50% decrease in rates of heme c1 and b reduction in the
enzyme with the S20T mutation, which is consistent with the
comparable drop in catalytic activity of this enzyme (Table 1).
The extent of reduction of heme b and heme c1 varies among
the bc1 complexes from the wild-type strains and the mutants.However, the ratios of the extent of reduction of c1 and b hemes
for the different enzymes are very similar,∼0.55. This indicates
that the mutations and the genetic background of the wild-type
yeast strain have no effect on the redox equilibrium between the
Rieske center and the c1 heme.
4. Discussion
In the current study we have examined the kinetic and
thermodynamic properties of the cytochrome bc1 complexes
from seven yeast strains with mutations in the vicinity of center
N [7,9,10]. Based on their location in relation to the ubiquinone
binding pocket and/or the bH heme we expected that these
mutations might affect center N kinetics. Trp-30 is highly
conserved in bacterial and mitochondrial cytochrome bc1 com-
plexes and forms a hydrogen bond with the propionate side
group of the bH heme (Fig. 1A). A hydrophobic interaction of
the ubiquinone with Met-221 appears also to be highly con-
served (Fig. 1A). Ser-20, Gln-22 and Leu-198, however, are not
conserved (Fig. 2). In the yeast structure, Leu-198 is in close
proximity of both the bH heme and ubiquinone. Ser-20 and Gln-
22 are within 5 Å of the ubiquinone ring and in close proximity
of Met-221. Ser-20 and Gln-22 also form a hydrogen-bonding
network that includes His-202, one of the carbonyl groups of
the ubiquinone ring, and an active-site water that is present in
the yeast structure but not in the structure from other species
(Fig. 1B).
The steady-state activities of bc1 complexes from the center
N mutants, with the exception of the S20T mutant, are very
similar to the activities of the enzymes of the wild-type yeast
they were derived from (Table 1). This is in agreement with the
growth phenotype on a non-fermentable carbon source and the
cytochrome c reductase activities of mitochondrial membranes
isolated from these mutants [7,9,10]. On the other hand, the
S20T mutation results in a 50% decrease in the turnover number
in a catalytic assay (Table 1) and significant decrease in pre-
steady-state kinetics through both center N (Fig. 6) and center
P (Fig. 7), although its growth phenotype and mitochondrial
cytochrome c reductase activity were comparable to those of the
wild-type yeast [7]. This indicates that solubilization with
detergent and column purification have global structural effects
on the enzyme of this mutant.
The mutation of leucine to a phenylalanine at position 198
(L198F) induces a small blue-shift in the maximum of the
α-band of the reduced cytochrome b (Fig. 3), indicating that the
bulkier hydrophobic residue alters the electronic environment
around the bH heme. This could occur through a direct inter-
action with the heme macrocycle, as is observed with the center
N inhibitors, antimycin or ilicicolin, binding of which near the
tetrapyrole ring also results in a shift in the absorbance max-
imum [23,24]. Alternatively, the mutation might have an indi-
rect effect on the histidine ligand to the heme iron, His-197. The
orientation of the axial imidazole ligand planes has been pro-
posed to play a significant role in modulating heme iron dπ
orbital energy levels [25]. A hydrophobic interaction with
phenylalanine may have changed this orientation. However, the
structural change seems to be subtle, based on the absence of a
Fig. 7. Pre-steady-state reduction of cytochrome b and cytochrome c1 by decyl-ubiquinol in the presence of antimycin. The top panels show the kinetic traces for the cytochrome bc1 complexes from the KM91 wild-type
strain, and the M221Q, M221E andW30C mutant strains. In these experiments 1 μM enzyme was reduced with 24 μM decyl-ubiquinol. The bottom panels show the kinetic traces for the cytochrome bc1 complexes from
the W303 wild-type strain, and the S20T, Q22E and L198F mutant strains. In these experiments 1 μM enzyme was reduced with 20 μM decyl-ubiquinol. The traces show cytochrome c1 reduction in gray and cytochrome
b reduction in black. Rates and extent of reduction are indicated for each trace, with values for bH heme reduction shown above the traces, and values for cytochrome c1 reduction shown below.
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Fig. 8. Structural changes resulting from the W30C cytochrome bmutation. The
figure shows the location of the W30C mutation in the non-helical region of
cytochrome b preceding helix A, proximal to heme bH. The calculated structure
of the non-helical region preceding helix A in the W30C mutant is colored
turquoise and overlaid on the structure of the non-helical region from the wild-
type enzyme. Trp-30 from the wild-type cytochrome b and Cys-30 from the
mutant are displayed simultaneously and labeled.
247F.A.J. Rotsaert et al. / Biochimica et Biophysica Acta 1777 (2008) 239–249change in the thermodynamic properties of the b hemes (Fig. 3,
Table 1) and only a small decrease in center N kinetics (Figs. 5,
6). Indeed, sequence analysis of the cytochrome b genes across
species shows that this residue is substituted by other larger
apolar residues, for example, a phenylalanine in C. glabrata or
isoleucine in R. capsulatus (Fig. 2).
In the W30C mutant, the spectral features of the combined b
hemes appear not to be altered, but the thermodynamic prop-
erties have changed. A shift in the redox midpoint potential of
the bH heme is obvious (Fig. 4A). Part of this change may result
from the larger van der Waals radius of the sulfur compared to
nitrogen, which has the effect of increasing electron density
proximal to the heme ring, as shown in Fig. 8. In addition, the
hydrogen bond between the nitrogen from the indole ring of the
tryptophan is lost, and modeling of the cysteine substitution into
the crystal structure of the yeast bc1 complex, followed by
energy minimization of the altered structure, suggests that the
cysteine sulfur may interact with the carboxylate group of a
propionate on the porphyrin ring (Fig. 8). Additional interactions
that are not shown by our calculations may accommodate the
loss of the large indole side-chain of the tryptophan. The result ofthese structural changes is either a more stable oxidized heme
iron, or a less stable reduced heme iron, thus lowering the redox
potential of the bH heme.
When the potentiometric titration curve for the enzyme with
the W30C mutation was fitted to a double Nernst equation the
best fit was obtained with both b hemes contributing equally to
the total absorbance of cytochrome b. This would suggest that
the W30C mutation has a long-range electronic effect on both
the bH and bL heme. This fit also suggests that the midpoint
potential of both the bL and bH heme has changed, by approx-
imately +20 mV and −20 mV, respectively, suggesting redox
interaction between the hemes. This long-range thermodynamic
effect on the heme near the quinol oxidation site at center P may
have modulated the kinetics of the bifurcated reaction, since a
small increase in the rate of cytochrome c1 reduction through
center P was observed (Fig. 7). On the other hand, a slightly less
satisfactory fit could be obtained by fixing the contribution of
the bL and bH heme at 30 and 70%, respectively, implying that
there is no long-range thermodynamic effect. In this case the
midpoint potential of the bH heme is decreased by ∼40 mV,
while the bL heme is unchanged. Regardless of which fit is
used, the lower thermodynamic driving force between the
decyl-ubiquinol substrate and the bH heme can readily explain
the slower reduction kinetics of the bH heme through center N
(Figs. 5, 6).
The midpoint potentials of the bH and bL heme in the bc1
complexes with mutations of Met-221 and Gln-22 were un-
changed (Table 1). This was expected, considering the location
of these residues, approximately 7 Å away from the bH heme
(Fig. 1B). Thus, the slowing in center N kinetics (Figs. 5, 6) can
be attributed to a change in the affinity of this site for the quinol
ligands and a pronounced drop in electron transfer rate, possibly
due to a change in electron transfer distance. Interestingly, the
total extent of reduction is not significantly different from that
of the wild-type enzyme, even for the M221E mutant that is the
most severely impaired in center N kinetics. This suggests that
the thermodynamic properties of the quinone are not perturbed
and that the binding geometry of quinone species has changed,
thus increasing the distance parameter for electron transfer. In
the M221Q and M221E mutants, the hydrophobic interaction
with the quinone is obviously lost and the replacement of
methionine with smaller residues widens the binding pocket. In
the bc1 complex from R. capsulatus, the loss of the hydrophobic
interaction by a F244L mutation, introducing a smaller iso-
leucine near the ubiquinone ring, resulted in an enzyme that was
not assembled or highly unstable [26]. This suggests that in the
yeast mutant enzymes, the glutamate and glutamine form new
interactions to stabilize the enzyme. Moreover, center N still has
a significant high affinity for the decyl-ubiquinol substrate
(Fig. 5) and an alternative binding conformation with a larger
distance between the quinone ring and bH heme may explain the
slower kinetics. The introduction of a larger, positively charged
lysine residue, as in the respiratory deficient M221K strain
blocked center N kinetics completely [12]. One possible expla-
nation is that the lysine residue prevents binding of ubiquinone.
Indeed, this mutation abolished binding of antimycin, a strong
center N inhibitor [12].
248 F.A.J. Rotsaert et al. / Biochimica et Biophysica Acta 1777 (2008) 239–249The effect on the center N kinetics due to the two Gln-22
mutations varies. The kinetics for the Q22T enzyme are
very similar to those of the wild-type enzyme (Figs. 5, 6).
This is somewhat surprising because this mutation may break
the hydrogen-bonding network around the active site water
(Fig. 1B) and open up the pocket around this residue. The high
substrate affinity suggests either that the hydrogen-bonded
water is not lost or is not critical for substrate binding, or the loss
of the hydrogen bond is compensated by new or existing
interactions. The Q22E substitution has a more dramatic effect
on the center N kinetics, possibly because the introduction of
the more electronegative glutamate residue near the ubiquinone
ring may destabilize the anionic semiquinone at center N.
The S20T mutation compromises both the rate and extent of
heme b reduction through center N (Figs. 5, 6). The affinity of
center N for quinone ligands is changed due to the S20T
mutation and probably plays the main role in the slower rate of
electron transfer through center N. Although the hydroxyl group
on the threonine may still be able to form a hydrogen bond with
the active site water in a similar orientation, the methyl group
will clash with Met-221. Thus subtle conformational changes
are required to accommodate this mutation, either by changing
the hydrogen-bonding network or reorienting the Met-221 and
its interaction with the ubiquinone.
The effect of the S20T mutation extends beyond center N.
The rates of reduction of b and c1 hemes through center P
dropped by ∼50%, which correlates with the drop in
cytochrome c reductase activity (Table 1). The lower extent of
reduction (Fig. 6) further suggests that the Rieske subunit has
been partly lost from this enzyme, and this is supported by the
titration curve for inhibition by stigmatellin (see Supplemental
data, Fig. 1. Interestingly, binding of ligand at center N has
previously been shown to have affects on the Rieske subunit
accessibility to protease at center P [27]. Considering the normal
wild-type activity of the S20T mutant in the membrane, we
conclude that the S20T mutation makes the enzyme more sus-
ceptible to degradation upon treatment with detergent. Another
ilicicolin H resistant yeast strain with a leucine substitution at
position 20 contained a labile bc1 complex in the membrane and
exhibited a 50% decrease in cytochrome c reductase activity [7].
Interestingly, a leucine residue naturally occurs in cytochrome b
from chicken and bovine, and another hydrophobic residue,
isoleucine, in cytochrome b from bacteria (Fig. 2, Ref. [19]). The
crystal structures of the bc1 complexes from these species [20–
22] show the loss of the active-site water and rotation of the
histidine towards the ubiquinone ring. This configuration is
stabilized by a direct hydrogen bond between the histidine and
the carbonyl group on the ring, and possibly also by an
interaction with leucine or isoleucine in these bc1 complexes.
Our data suggest that structural differences around His-202
(yeast sequence) are important for optimal center N kinetics and
stability of the bc1 complexes from different species.
In conclusion, the center N mutants characterized here show
that lowering the redox potential of the bH heme and, moreover,
expansion of the volume within center N slows down electron
transfer between quinol and the bH heme. Therefore, conserving
a narrow volume within the center N pocket appears to be animportant factor to allow fast electron transfer between the
quinone ligands and the bH heme, as well as to promote the
formation of the semiquinone intermediate [28].
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